Remimazolam Consumption: TCI vs. Manual Infusion

Recruiting now · Not applicable

Conditions studied: Moyamoya Disease

In brief

The purpose of this prospective randomized controlled trial is to compare the total consumption of remimazolam between two different administration methods-Target-Controlled Infusion (TCI) and manual infusion-in patients undergoing cerebrovascular bypass surgery.

Key facts

Study ID

NCT07377695

Run by

Seoul National University Hospital

People needed

58

Starts

2026-02-04

Expected to finish

2030-12-31

Last updated by the study team

2026-04-23

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients scheduled to undergo cerebrovascular bypass surgery under general anesthesia.
• American Society of Anesthesiologists (ASA) Physical Status 1, 2, or 3
• Adults aged 19 years or older
• Patients who have provided prior written informed consent to participate in the study

You may not qualify if…

• Patients who do not consent to participate in the research
• Patients classified as ASA Physical Status 4
• Patients with a BMI ≤18.5 kg/m2 or 35.0 ≥ kg/m2
• History of allergy to benzodiazepine-class medications
• Patients with acute narrow-angle glaucoma
• Patients in a state of shock or coma
• Acute alcohol intoxication with suppressed vital signs , or patients with alcohol or drug dependency
• Presence of Sleep Apnea Syndrome or severe/acute respiratory failure
• Patients with lactose intolerance or hypersensitivity to Dextran 40

Where it is running

• Seoul National University Bundang Hospital — Seongnam-si, Gyeonggi-do, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.